Money Lancer
Equity: Sectoral-Pharma and Healthcare
SBI Mutual Fund
SBI Mutual Fund · Equity: Sectoral-Pharma and Healthcare

SBI Healthcare Opportunities Fund - Regular Plan -Growth

To provide the investors with the opportunity of long term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.

EquityBenchmark · BSE Healthcare TRITER · 1.90%Inception · 14-07-1999
NAV
459.29
-0.01% · as of 31-05-2026
Since inception
15.29%
CAGR
Benchmark (inception)
14.72%
CAGR
Fund size
₹4,323 Cr
AUM
Expense ratio
1.90%
30-04-2026
Performance

Returns vs benchmark & category

Since inception: +15.29% CAGR vs benchmark +14.72%.

Portfolio

Where the money is invested

Top holdings

SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/-12.11%
DIVIS LABORATORIES LIMITED EQ NEW RS. 2/-6.59%
Ami Organics Limited5.67%
APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/-5.48%
MAX HEALTHCARE INSTITUTE LIMITED EQ4.97%
LUPIN LIMITED EQ NEW F.V. RS.2/-4.10%
ASTER DM HEALTHCARE LIMITED EQ3.96%
TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/-3.74%
AETHER INDUSTRIES LIMITED EQ3.56%
TREPS3.36%

Sector allocation

Healthcare91.22%
Chemicals3.56%
Consumer Services0.41%
Riskometer
LowVery High
Very High

What if you'd SIP'd here?

@ 15.3% p.a.
₹10,000
10 years
Projected value
₹28,36,906
Invested: ₹12,00,000
Gained: ₹16,36,906
Start this SIP →

Illustration based on fund's since-inception return. Past performance is not indicative of future returns.

Risk Analysis

How this fund manages risk

Fund manager
M
Mr. Tanmaya Desai
Manager since fund inception data not available
ISIN & identifiers
AMFI code
102823
ISIN (Growth)
INF200K01446
ISIN (Div Re-inv)
Status
Open Ended Schemes
Peers

Other Equity: Sectoral-Pharma and Healthcare funds

Want a personalised recommendation?

Our team will tell you whether this fund fits your goals, allocation and risk profile — and suggest peers if it doesn't.

Chat with us